This non-comparative study explored the benefits of a natural gelling fibre dressing in 10 children with epidermolysis bullosa (EB). The clinical challenge in managing these children is that they often present with recalcitrant wounds that are perpetuated by critical colonisation, presence of biofilms and infection. KytoCel ® (Aspen Medical) is a highly absorbent dressing composed of natural, biodegradable acylated chitosan. These fibres bond with wound exudate to form a clear gel that locks in fluid absorbs pathogens and is conformable to the wound bed. It also has haemostatic properties. 
Use of fibre dressings in children with severe epidermolysis bullosa E pidermolysis bullosa (EB) is an umbrella term for a large group of genetically determined skin fragility disorders (Denyer, 2006) . Reduced or absent vital proteinsleadtoalackoftensilestrengthwithintheskin andmucousmembranes,resultinginblistersorskinstripping followingminorfrictionandtrauma.SevereEBleadstoearly development of recalcitrant wounds that are perpetuated by criticalcolonisation,presenceofbiofilmsandinfection.Inline withcurrentrecommendationandtoavoidfurtherantibiotic resistanceinchildrenwithEB,iflocalcolonisationofwounds isobservedtheuseoftopicalantimicrobialagentsareadvised. Antibioticuseshouldbereservedforseveresystemicinfections causedbyGroupAstreptococcus.
Studiesonsilverdressingsinyoungadultsandchildrenhave demonstratedanuptakeofsilverlevelsintheplasma,urine and the liver (Trop et al, 2006) .This caused great concern and debate between wound care specialists throughout the UK. (Hipler and Elsner, 2006; Leaper, 2011; White et al 2011) .AsaresultofthesefindingsEBbestpracticeguidelines statethat:
Jacqueline Denyer and Elaine Gibson
'Silver products should be used with caution in infants under one year. Also potential risk of raised plasma silver levels/argyria. Restrict use to 14 days and apply to a small area for short-term use only.' (Denyer and Pillay, 2012) All children that present with EB undergo a skin biopsy todeterminetheseverityofthedisease.Thiscausesbleeding and trauma in what is already very delicate skin. Kytocel ® (Aspen Medical), a new natural gelling fibre dressing with antimicrobial properties that does not contain silver, that can also be used as a haemostat (to control bleeding), was evaluated in 10 children with EB ranging from simplex to severedystrophicEBbetweenAprilandAugust2014.Factors consideredwerewhetherthedressingcould:
Product selection
The natural gelling fibre dressing used for this study is highly absorbent. It is composed of natural, biodegradable acylatedchitosanThesefibresbondwithwoundexudateto formacleargelthatlocksinfluid,absorbspathogensandis conformable to the wound bed (Lee et al, 2009; StephenHaynes et al, 2014) . Chitosan is a naturally occurring starch (polymer) derived from the shells of crustaceans. The absorbent properties enable it to bind and lock away commonlyencounteredwoundpathogenssuchasEscherichia coli, Staphylococcus aureus, Candida Albicans and methicillinresistant Staphylococcus aureus (Edward-Jones, 2014) . The positive charge of chitosan fibres facilitates haemostasis by binding to negatively charged red blood cells, resulting in faster coagulation. (Khor and Lim, 2003; Dutta et al, 2004; Foda et al, 2007) .This ability to reduce bioburden, absorb exudate and encourage coagulation is an advantage in children with EB where skin breakdown, bleeding and resultinginfectionremainachallenge.
EB simplex
TherearethreemaincategoriesofEBsimplex:EBSlocalised, EBSgeneralised-severeandEBSgeneralised-other (Denyer, 2010; Fineetal,2014) Almost all forms of EB simplex are generally inherited autosomal dominantly (from one parent). Inheriting a disease such as EB depends on the type of chromosome Dystrophic EB (DEB) DEBcanbeinheritedeitherdominantlyorrecessively,with themoresevereformsingeneral,beinginheritedrecessively (DenyerandPillay,2012 (Haynes, 2010) . There is an increased risk of aggressive squamous cellcarcinomainthosewithsevereformsofEB (Fineetal, 2009) .
Recessive dystrophic EB
In recessive dystrophic EB the affected child is able to express some type-VII collagen, with variable qualitative and quantitative abnormalities of the anchoring fibrils.The clinicalpresentationwillvarywithatendencytoblistering all over the body and consequent wounding, scarring and nail loss. The development of anaemia is common with this type of EB and there is often mucosal involvement. Thehandswillbescarredwithsomewebbingasaresultof constantremodellingofthedelicateskin.
Recessive dystrophic EB severe-generalised
InthisformofEBtheskinisextremelyfragile,oftenwith extensive blistering and wounding. Patients with this type of EB will frequently develop hard-to-heal or never-tohealareas,orareasthatdohealbutcanveryquicklybreak down. Atrophic scarring and healing leading to disabling contracturesiscommon.
This article discusses the various sub-types of EB where Kytocel was used. More information and guidelines pertainingtoEBcanbefoundatwww.debra.org.
Assessment and diagnosis
WithineachofthefourcategoriesofEBtherearesubtypes thatdisplayindividualclinicaleffectsDefinitivediagnosisis most commonly made from analysis of a skin biopsy using positive immunofluorescence (IF), antigenic mapping and transmissionelectronmicroscopy(EM).Thesekeydiagnostic tools help to confirm diagnosis and indicate the particular sub-type of EB. Identification of the different causative genes responsible for EB enables the recognition of the preciselocationandtypeofmutation.Owingtotherarityof expertiseandfacilities,however,diagnosisisgenerallymade usingIFandantigenmapping. (DenyerandPillay,2012) Method A total of 10 children with a varying range of EB from simplex to severe dystrophic disease were selected for the study. Criteria included those with chronic wounds which were critically colonised or where presence of a biofilm was suspected, or following skin biopsy for EB diagnosis.
affected. It also depends on whether the trait is dominant orrecessive.Asingleabnormalgeneononeofthefirst22 non-sex (autosomal) chromosomes from either parent can cause an autosomal EB-dominant inheritance, meaning an abnormal gene from one parent can cause disease, even thoughthematchinggenefromtheotherparentisnormal. The abnormal gene dominates (Lupsik, 2011) . Most EB simplex is a disorder of keratin proteins with the primary defects lying within proteins encoding for keratin 5 and keratin 14.Theseproteinsformthemajorkeratinscaffolding withinthebasalepidermalcells.Dysfunctionofthekeratin proteinsinEBsimplexleadstomechanicalweaknessofthese cells.Beakdownoccursbecauseofminorfrictionorrubbing resulting in blistering of the hands and feet that can be presentevenintheneonatalperiod.Thereisasignificantrisk ofdeathinthemoresevereformsofsimplexEB,resulting fromsepisandlaryngealblistering (FineandHintner,2008) . TherearethreemainformsofjunctionalEB(Nakanoetal, 2002; Uittoetal,2007; Fineetal,2008; DenyerandPillay, 2012) .
Junctional EB
AllformsofjunctionalEBarisefrommutationsingenes thatencodestructuralcomponentsofthehemidesmosomes oranchoringfilaments,whichprovidemechanicalintegrity across the dermis and epidermis. Targeted proteins are laminin 332, type-XVII collagen and ą6 ß4 integrin. Separation of the epithelium occurs within the lamina lucidabetweenthelaminadensaofthebasementmembrane involvingbasalkeratinocytes.InallformsofjunctionalEB, There is a tendency for chronic wounds to over-granulate inpatientsfromanearlyage (Nakanoetal,2002; Fineand Hinter,2008) .
This severe sub-type carries a poor prognosis with most not surviving beyond the first 2 years of life (Pillay, 2008; Fine and Hinter, 2008) . Death is caused by a combination of laryngeal blistering/respiratory distress, a profound and uncorrectable failure to thrive, chronic wounds and sepsis (Laimer et al, 2010) . Despite the severity of the systemic disease, good management can help reduce the severity of thewounds. 
Junctional EB (JEB) intermediate

Final dressing evaluation
Results
Seven girls and three boys were recruited with ages ranging from 10 months to 16 years, with a mean age of 7 years 2months.Thebreakdownwassixpatientswithsevere generalisedrecessivedystrophicEB,twowithjunctionalEB, onewithLOCsyndromeandonewithsimplexEB. Exudate levels were measured between week 1-4, observationsweremaderegardingtheabilityofthedressing to absorb fluid and reduce bioburden (case studies 1, 2, and 3).The cause of injury was noted as it was felt that the new dressing had the potential to improve outcomes, particularly when taking skin biopsy for diagnosis in new born infants (Figure 1) .The most common cause of injury wasfrictionandsheer(asshownincasestudy3)causedby theflangeofatracheostomy.Thepatientincasestudy1had multi-resistant Pseudomonas aeruginosa (P. aeruginosa) blisters on her hands and feet. Children with EB are commonly referredtoas'butterflychildren' (AthertonandDenyer,2003; Laimer et al, 2010 ) because the skin is so fragile,andthishasbeenwelldocumentedintheliterature.
Exudate levels were recorded as low, medium-heavy or veryheavy.Thiswasdocumentedandratedbybothclinicians andparents.Exudatelevelsvarieddependingontheseverity of the EB and the amount of blistered skin or tissue loss. Thedressingprovedeffectiveinmanagingmoderatetohigh exudate levels. In one patient the wound adhered to the woundmargins,andasiliconeprimarylayerwasrequiredto Further studies in the use of chitosan dressings in this group of patients will be helpful.The author plans to try the products on neonates suffering wounds from prenatal activityandbirthtraumatoseewhetherthehealingprocess isaccelerated.
Case study 1
An 8-year-old girl with EB simplex localised had severe blistering on her feet which became worse in hot weather. Theulceratedareaonherfootbecameheavilycolonisedand inflamed (Figure 3a) .Kytocelwasgentlypackedintotheulcer with KerraLite Cool Border (Crawford Healthcare) applied as a secondary dressing. The dressings were changed daily as she likes to soak her feet daily in cool water after school. The ulcer appeared cleaner at the first dressing change. By 25 May (Figure 3b) ,thewoundbedwashealthier,exudatelevels reducedfrommediumtolow,andnosmellwasdetected.By 28 May (Figure 3c ) the wound was superficial and no longer requiredpackingwithKytocelribbon.Thewoundwentonto heal2weekslater.
Case study 2
An 11-year-old boy presented with severe generalised recessive dystrophic EB with the added complications of anaemia and malabsorption syndrome. Nutrition was poor and he was increasingly obtaining chronic wounds. He is very particular about his choice of dressings and has refused topicalantimicrobialsinthepast.Afteralotofencouragement he agreed to try Kytocel under his usual dressing on one wound on his right shoulder that had failed to heal in 2 months (Figure 4a) .Thedressingwerechangedeveryotherday. After the first dressing change there was a marked reduction in exudate (Figure 4b) . The wound appeared clean and as the exudate level decreased the Kytocel became increasing adherenttothewoundcausingdistressonremoval.Applying an atraumatic dressing as a wound contact layer (Urgotul, Urgo Medical) prevented adherence and did not reduce the efficacy of Kytocel. The authors would recommended this dressingapproachwherethereisaneedtoreducethewound bioburdenandthereisanyconcernregardingadherenceowing tolowexudatelevels.
Thewoundhealedbyday10 (Figure 4c ).
Case study 3
This3-year-oldgirlpresentedwithLOCsyndrome.Blistering and development of granulomas within her trachea meant she was dependent upon a tracheostomy for her survival. It isessentialthatthetubedoesnotbecomedislodgedandthe securingtapesmustthereforebeverytight.Theflangeofthe tracheostomytuberubbedagainstherfragileskincausingan area of ulceration. She developed a multidrug-resistant strain of pseudomonas in her sputum.The wound quickly became colonised, associated with bleeding friable tissue (Figure 5a) . The wound had failed to heal for 25 days. KytoCel was appliedtothewoundwithKerraLiteCoolBorderappliedas a secondary dressing.The dressing was changed daily (Figure 
KEY POINTS
n Wound management remains a clinical challenging in supporting epidermolysis bullosa children and their families n This article reports on an alternative gelling fibre dressing that reduced bioburden, managed exudate and helped stop bleeding where there was trauma or critical colonisation in the cases reported n Applying an atraumatic dressing as a wound-contact layer prevented adherence where there was little or no exudate and did not reduce the efficacy of the dressing n Improvements in recalcitrant wounds where all other therapies have failed were encouraging PRODUCT FOCUS ©2015MAHealthcareLtd 5b).Within 2 weeks bleeding and exudate had reduced and the wound had reduced in size.At 19 days the wound had healed (Figure 5c) andwoundswabsconfirmederadicationof pseudomonas,despitethefacthersputumremainscolonised.
Conclusion
Early results have indicated in this small pilot study that KytoCeldressingsarehelpfulintreatingrecalcitrantwounds inpatientswithsevereformsofEB.Theauthorsrecommend that further studies be undertaken extending to adult EB patients to see whether the same benefits can improve patientsoutcomes. 
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